Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Dynamic Dystroglycan Complexes Mediate Cell Entry of Lassa Virus.

Herrador A, Fedeli C, Radulovic E, Campbell KP, Moreno H, Gerold G, Kunz S.

MBio. 2019 Mar 26;10(2). pii: e02869-18. doi: 10.1128/mBio.02869-18.

2.

Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry Factors.

Zapatero-Belinchón FJ, Dietzel E, Dolnik O, Döhner K, Costa R, Hertel B, Veselkova B, Kirui J, Klintworth A, Manns MP, Pöhlmann S, Pietschmann T, Krey T, Ciesek S, Gerold G, Sodeik B, Becker S, von Hahn T.

Viruses. 2019 Mar 19;11(3). pii: E275. doi: 10.3390/v11030275.

3.

Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB.

Bruening J, Lasswitz L, Banse P, Kahl S, Marinach C, Vondran FW, Kaderali L, Silvie O, Pietschmann T, Meissner F, Gerold G.

PLoS Pathog. 2018 Jul 19;14(7):e1007111. doi: 10.1371/journal.ppat.1007111. eCollection 2018 Jul.

4.

Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.

Abere B, Samarina N, Gramolelli S, Rückert J, Gerold G, Pich A, Schulz TF.

J Virol. 2018 Aug 16;92(17). pii: e00544-18. doi: 10.1128/JVI.00544-18. Print 2018 Sep 1.

5.

Glycomics and Proteomics Approaches to Investigate Early Adenovirus-Host Cell Interactions.

Lasswitz L, Chandra N, Arnberg N, Gerold G.

J Mol Biol. 2018 Jun 22;430(13):1863-1882. doi: 10.1016/j.jmb.2018.04.039. Epub 2018 May 7. Review.

PMID:
29746851
6.

CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.

Banse P, Moeller R, Bruening J, Lasswitz L, Kahl S, Khan AG, Marcotrigiano J, Pietschmann T, Gerold G.

Viruses. 2018 Apr 20;10(4). pii: E207. doi: 10.3390/v10040207.

7.

Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan.

Fedeli C, Torriani G, Galan-Navarro C, Moraz ML, Moreno H, Gerold G, Kunz S.

J Virol. 2018 Feb 12;92(5). pii: e01613-17. doi: 10.1128/JVI.01613-17. Print 2018 Mar 1.

8.

The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.

Bruening J, Weigel B, Gerold G.

J Immunol Res. 2017;2017:7232361. doi: 10.1155/2017/7232361. Epub 2017 Feb 1. Review.

9.

Protein Interactions during the Flavivirus and Hepacivirus Life Cycle.

Gerold G, Bruening J, Weigel B, Pietschmann T.

Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S75-S91. doi: 10.1074/mcp.R116.065649. Epub 2017 Jan 11. Review.

10.

Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.

von Schaewen M, Dorner M, Hueging K, Foquet L, Gerges S, Hrebikova G, Heller B, Bitzegeio J, Doerrbecker J, Horwitz JA, Gerold G, Suerbaum S, Rice CM, Meuleman P, Pietschmann T, Ploss A.

MBio. 2016 Nov 8;7(6). pii: e01915-16. doi: 10.1128/mBio.01915-16.

11.

ABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus Production.

Vieyres G, Welsch K, Gerold G, Gentzsch J, Kahl S, Vondran FW, Kaderali L, Pietschmann T.

PLoS Pathog. 2016 Apr 28;12(4):e1005568. doi: 10.1371/journal.ppat.1005568. eCollection 2016 Apr.

12.

Decoding protein networks during virus entry by quantitative proteomics.

Gerold G, Bruening J, Pietschmann T.

Virus Res. 2016 Jun 15;218:25-39. doi: 10.1016/j.virusres.2015.09.006. Epub 2015 Sep 10. Review.

13.

A molecular tweezer antagonizes seminal amyloids and HIV infection.

Lump E, Castellano LM, Meier C, Seeliger J, Erwin N, Sperlich B, Stürzel CM, Usmani S, Hammond RM, von Einem J, Gerold G, Kreppel F, Bravo-Rodriguez K, Pietschmann T, Holmes VM, Palesch D, Zirafi O, Weissman D, Sowislok A, Wettig B, Heid C, Kirchhoff F, Weil T, Klärner FG, Schrader T, Bitan G, Sanchez-Garcia E, Winter R, Shorter J, Münch J.

Elife. 2015 Aug 18;4. pii: e05397. doi: 10.7554/eLife.05397.

14.

Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry.

Gerold G, Meissner F, Bruening J, Welsch K, Perin PM, Baumert TF, Vondran FW, Kaderali L, Marcotrigiano J, Khan AG, Mann M, Rice CM, Pietschmann T.

Cell Rep. 2015 Aug 4;12(5):864-78. doi: 10.1016/j.celrep.2015.06.063. Epub 2015 Jul 23.

15.

Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice.

Scull MA, Shi C, de Jong YP, Gerold G, Ries M, von Schaewen M, Donovan BM, Labitt RN, Horwitz JA, Gaska JM, Hrebikova G, Xiao JW, Flatley B, Fung C, Chiriboga L, Walker CM, Evans DT, Rice CM, Ploss A.

Hepatology. 2015 Jul;62(1):57-67. doi: 10.1002/hep.27773. Epub 2015 Apr 15.

16.

The HCV life cycle: in vitro tissue culture systems and therapeutic targets.

Gerold G, Pietschmann T.

Dig Dis. 2014;32(5):525-37. doi: 10.1159/000360830. Epub 2014 Jul 14. Review.

17.

A circuit of paracrine signals between liver sinusoid endothelial cells and hepatocytes regulates hepatitis C virus replication.

Gerold G, Pietschmann T.

Hepatology. 2014 Feb;59(2):363-5. doi: 10.1002/hep.26621. Epub 2013 Dec 23. No abstract available.

PMID:
23857467
18.

Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.

Vogt A, Scull MA, Friling T, Horwitz JA, Donovan BM, Dorner M, Gerold G, Labitt RN, Rice CM, Ploss A.

Virology. 2013 Sep;444(1-2):1-11. doi: 10.1016/j.virol.2013.05.036. Epub 2013 Jun 16.

19.

Hepatitis C virus NS5B polymerase primes innate immune signaling.

Gerold G, Pietschmann T.

Hepatology. 2013 Mar;57(3):1275-7. doi: 10.1002/hep.26201. Epub 2013 Feb 21. No abstract available.

PMID:
23426794
20.

Characterization of a canine homolog of hepatitis C virus.

Kapoor A, Simmonds P, Gerold G, Qaisar N, Jain K, Henriquez JA, Firth C, Hirschberg DL, Rice CM, Shields S, Lipkin WI.

Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11608-13. doi: 10.1073/pnas.1101794108. Epub 2011 May 24.

Supplemental Content

Loading ...
Support Center